MAPT and Alzheimer disease: Alzheimer’s disease (AD), the most common neurodegenerative disease worldwide, is characterized by progressively impaired cognition, an excessive accumulation of amyloid-β (Aβ), and abnormally hyperphosphorylated tau in the brain (Jack et al., 2013; Song, 2019).